BioNTech
Washington (AFP) - Moderna said Friday it is suing rival vaccine makers Pfizer and BioNTech, alleging the partners infringed on its patents in developing their Covid-19 shot administered to hundreds of millions around the world. The lawsuits set up a high-stakes showdown between the leading manufacturers of Covid-19 shots that are a key tool in the fight against the disease. "Moderna believes that Pfizer and BioNTech's Covid-19 vaccine Comirnaty infringes patents Moderna filed between 2010 and 2016 covering Moderna's foundational mRNA technology," the US-based biotech firm said in a statement....
AFP
Washington (AFP) - Pfizer and BioNTech announced Thursday they would seek regulatory authorization for a third dose of their Covid-19 vaccine. It comes after initial data from an ongoing trial showed a third shot pushed antibody levels five to 10 times higher against the original coronavirus strain and the Beta variant, first found in South Africa, compared to the first two doses alone, according to a statement. "The companies expect to publish more definitive data soon as well as in a peer-reviewed journal and plan to submit the data to the FDA (Food and Drug Administration), EMA (European Me...
AFP
Paris (AFP) - With a strategic alliance, 24-hour production and a bit of luck, Pfizer and BioNTech were able to roll out their Covid vaccine at a brisk pace and relatively free of controversy. US pharmaceutical giant Pfizer and BioNTech, a smaller German biotech firm, joined forces on April 9, 2020, as the world reeled from the pandemic, with deaths soaring and nations under lockdown. The companies set an ambitious goal: Producing hundreds of millions of jabs in 2021 -- an incredibly short timeline when vaccines usually take years to develop and secure regulatory approval. Seven months later, ...
AFP
Frankfurt am Main (AFP) - Europe's medicines regulator said Tuesday it would decide by December 29 whether to grant emergency approval to a Covid-19 vaccine developed by Germany's BioNTech and its US partner Pfizer, ahead of a rival treatment from Moderna.The European Medicines Agency (EMA) confirmed that it had received formal applications from both vaccine makers seeking the green light for their experimental jabs."If the data submitted are robust enough to conclude on the quality, safety and effectiveness of the vaccine," the Amsterdam-based agency said it could conclude its assessment of t...
AFP
Washington (AFP) - An emergency use authorization request for the Covid-19 vaccine developed by Pfizer and BioNTech was expected to be filed with the FDA on Friday, the US government and BioNTech's co-founder said.This type of Food and Drug Administration authorization is temporary or conditional and is granted in response to an emergency situation such as a pandemic."Pfizer's partner BioNTech has announced that tomorrow they intend to file for emergency use authorization at the FDA," health secretary Alex Azar told a press conference Thursday in Washington.BioNTech co-founder Ugur Sahin earli...
AFP
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら